Zusammenfassung
Der hämorrhagische Schock wird mit Gegenregulationsmechanismen des Organismus beantwortet, die zumindest ein temporäres Überleben ermöglichen. Hier können neue Therapiestrategien ansetzen. Die Zukunft der Schockbehandlung wird vom wissenschaftlichen Erkenntnisgewinn und der Bereitschaft der Ärzte abhängen, etablierte Therapiekonzepte zu aktualisieren. Die vier Hauptzielgrößen der zukünftigen Schockbehandlung sind: Blutungskontrolle durch lokale blutstillende Maßnahmen und eine Optimierung des Gerinnungssystems; Erhöhung des intravaskulären Volumens durch Ausschöpfung venöser Blutreserven (Vermeidung von Fehlern bei der kontrollierten Beatmung, Einsatz alternativer Spontan- bzw. Beatmungskonzepte, Infusion von künstlichen Sauerstoffträgern); pharmakologische Interaktion mit endogenen Kompensations- und Dekompensationsmechanismen (Gabe von Arginin-Vasopressin und ATP-sensitiven Kalium-Kanal-Blockern); Anwendung protektiver Maßnahmen (Induktion einer moderaten Hypothermie). Ultimative Zukunftsvision in der Behandlung des vital bedrohlichen hämorrhagischen Schocks ist die „suspended animation“ im Sinne einer postponierten Wiederbelebung nach Protektion vitaler Organsysteme.
Abstract
The future of shock treatment depends on the importance of scientific results, and the willingness of physicians to optimize, and to reconsider established treatment protocols. There are four major potentially promising approaches to advanced trauma life support. First, control of hemorrhage by administration of local hemostatic agents, and a better, target-controlled management of the coagulation system. Second, improving intravascular volume by recruiting blood from the venous vasculature by preventing mistakes during mechanical ventilation, and by employing alternative spontaneous (i.e. use of the inspiratory threshold valve) or artificial ventilation strategies. In addition, artificial oxygen carriers may improve intravascular volume and oxygen delivery. Third, pharmacologic support of physiologic, endogenous mechanisms involved in the compensation phase of shock, and blockade of pathomechanisms that are known to cause irreversible vasoplegia (arginine vasopressin and KATP channel blockers for hemodynamic stabilization). Fourth, employing potentially protective strategies such as mild or moderate hypothermia. Finally, the ultimate vision of trauma resuscitation is the concept of “suspended animation” as a form of delayed resuscitation after protection of vital organ systems.
Literatur
Adnet F, Lapostolle F, Ricard-Hibon A, Carli P, Goldstein P (2001) Intubating trauma patients before reaching hospital—revisited. Crit Care 5:290–291
Alam HB, Uy GB, Miller D et al. (2003) Comparative analysis of hemostatic agents in a swine model of lethal groin injury. J Trauma 54:1077–1082
Armand R, Hess JR (2003) Treating coagulopathy in trauma patients. Transfus Med Rev 17:223–231
Aufderheide TP, Sigurdsson G, Pirrallo RG et al. (2004) Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation 109:1960–1965
Bickell WH, Wall MJJ, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox K (1994) Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331:1105–1109
Bochicchio G, Scalea T (2003) Is field intubation useful? Curr Opin Crit Care 9:524–529
Bochicchio G, Ilahi O, Joshi M, Bochicchio K, Scalea T (2003) Endotracheal intubation in the field does not improve outcome in trauma patients who present without an acutely lethal traumatic brain injury. J Trauma 54:307–311
Bond RF, Johnson G 3rd (1985) Vascular adrenergic interactions during hemorrhagic shock. Fed Proc 44:281–289
Brayden JE (2002) Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29:312–316
Burris D, Rhee P, Kaufmann C et al. (1999) Controlled resuscitation for uncontrolled hemorrhagic shock. J Trauma 46:216–223
Cannon W, Fraser J, Cowell E (1918) The preventative treatment of wound shock. JAMA 70:618–621
Chan L, Bartfield JM, Reilly KM (1997) The significance of out-of-hospital hypotension in blunt trauma patients. Acad Emerg Med 4:785–788
Coats TJ, Goode A (2001) Towards improving prehospital trauma care. Lancet 357:2070
Cole WC, Clement-Chomienne O (2003) ATP-sensitive K+ channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol 14:94–103
Convertino VA, Ratliff DA, Ryan KL et al. (2004) Effects of inspiratory impedance on the carotid-cardiac baroreflex response in humans. Clin Auton Res 14:240–248
Cournard A, Motley HL, Werko L, Richards DW (1948) Physiologic studies of the effects of intermittent positive pressure breathing on cardiac output in man. Am J Physiol 152:162–174
Driessen B, Jahr JS, Lurie F, Golkaryeh MS, Gunther RA (2003) Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study. Crit Care Med 31:1771–1779
Dutton R (2002) Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 52:1141–1146
Ericsson BF (1971) Hemodynamic effects of vasopressin. An experimental study in normovolemic and hypovolemic anesthetized dogs. Acta Chir Scand Suppl 414:1–29
Errington ML, Rocha e Silva M Jr (1972) Vasopressin clearance and secretion during hemorrhage in normal dogs and in dogs with experimental diabetes insipidus. J Physiol 227:395–418
Evgenov OV, Pacher P, Williams W et al. (2003) Parenteral administration of glipizide sodium salt, an inhibitor of adenosine triphosphate-sensitive potassium channels, prolongs short-term survival after severe controlled hemorrhage in rats. Crit Care Med 31:2429–2436
Fewell JE, Abendschein DR, Carlson CJ, Murray JF, Rapaport E (1980) Continuous positive-pressure ventilation decreases right and left ventricular end-diastolic volume in the dog. Circ Res 46:125–132
Forrest P (2001) Vasopressin and shock. Anaesth Intensive Care 29:463–472
Franklin GA, Boaz PW, Spain DA, Lukan JK, Carillo EH, Richardson JD (2000) Prehospital hypotension as a valid indicator of trauma team activation. J Trauma 48:1037–1039
Goldsmith SR (1987) Vasopressin as vasopressor. Am J Med 82:1213–1219
Goodin TH, Grossbard EB, Kaufman RJ, Richard TJ, Kolata RJ, Allen JS, Layton TE (1994) A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study. Crit Care Med 22:680–689
Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Moss GS (1986) Polymerized pyridoxylated hemoglobin: efficacy as an O2 carrier. J Trauma 26:903–908
Gould SA, Moore EE, Hoyt DB et al. (2002) The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 195:445–452
Guyton AC (1991) Circulatory shock and physiology of its treatment. In: Guyton AC (ed) Textbook of medical physiology. Saunders, Philadelphia, pp 263–271
Haas T, Voelckel WG, Wiederman F, Wenzel V, Lindner KH (2004) Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressn: a case report and brief review of the literature. J Trauma 57:177–179
Habler OP, Messmer KF (2000) Tissue perfusion and oxygenation with blood substitutes. Adv Drug Deliv Rev 40:171–184
Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F (2001) Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 15:316–321
Heckbert SR, Vedder NB, Hoffman W et al. (1998) Outcome after hemorrhagic shock in trauma patients. J Trauma 45:545–549
Helm M, Hauke J, Sauermüller G, Lampl L, Bock K (1999) Quality of emergency ventilation. A prospective study of trauma patients. Unfallchirurg 102:347–353
Henderson RA, Whitehurst ME, Morgan KR, Carroll RG (2000) Reduced metabolic rate accompanies the hemorrhage-induced hypothermia in conscious rats. Resuscitation 44:129–138
Henderson RA, Whitehurst ME, Morgan KR, Carroll RG (2000) Reduced oxygen consumption precedes the drop in body core temperature caused by hemorrhage in rats. Shock 13:320–324
Hierholzer C, Billiar TR (2001) Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386:302–308
Jacobsen J, Sofelt S, Sheikh S, Warberg J, Secher NH (1990) Cardiovascular and endocrine responses to haemorrhage in the pig. Acta Physiol Scand 138:167–173
Jeroukhimov I, Jewelewicz D, Zaias J et al. (2002) Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury. J Trauma 53:1053–1057
Keipert PE, Faithfull NS, Roth DJ, Bradley JD, Batra S, Jochelson P, Flaim KE (1996) Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv Exp Med Biol 388:603–609
Kerger H, Tsai AG, Saltzman DJ, Winslow RM, Intaglietta M (1997) Fluid resuscitation with O2 vs. non-O2 carriers after 2 h of hemorrhagic shock in conscious hamsters. Am J Physiol 272:H525–537
Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U (2003) DCL-Hb for trauma patients with severe hemorrhagic shock: the European „On-Scene“ multicenter study. Intensive Care Med 29:378–385
Kettner SC, Sitzwohl C, Zimpfer M, Kozek SA, Holzer A, Spiss CK, Illievich UM (2003) The effect of graded hypothermia (36 degrees C-32 degrees C) on hemostasis in anesthetized patients without surgical trauma. Anesth Analg 96:1772–1776
Khanna S, Sibbald JR, Smith DW, Day TA (1994) Initiation of rat vasopressin cell responses to simulated hypotensive hemorrhage. Am J Physiol 267:R1142
Kim SH, Stezoski SW, Safar P, Capone A, Tisherman S (1997) Hypothermia and minimal fluid resuscitation increase survival after uncontrolled hemorrhagic shock in rats. J Trauma 42:213–222
Kirimli B, Kampschulte S, Safar P (1968) Cardiac arrest from exsanguination in dogs. Evaluation of resuscitation methods. Acta Anaesthesiol Scand Suppl 29:183–189
Kirimli B, Kampschulte S, Safar P (1969) Resuscitation from cardiac arrest due to exsanguination. Surg Gynecol Obstet 129:89–97
Krause KR, Howells GA, Buhs CL, Hernandez DA, Bair H, Schuster M, Bendick PJ (2000) Hypothermia-induced coagulopathy during hemorrhagic shock. Am Surg 66:348–354
Kreimeier U (2001) Blood volume—What brings us to the new millennium? Anaesthesist 50:429–431
Kreimeier U, Messmer K (1995) What is new in shock research? Chirurg 66:1029–1039
Kreimeier U, Messmer K (1996) Prehospital fluid resuscitation. Anaesthesist 45:884–899
Kreimeier U, Prueckner S, Peter K (2000) Permissive hypotension. Schweiz Med Wochenschr 130:1516–1524
Kreimeier U, Peter K, Messmer K (2001) Small volume—Large benefits? Anaesthesist 50:442–449
Kreimeier U, Lackner CK, Pruckner S, Ruppert M, Peter K (2002) Permissive Hypotension beim schweren Trauma. Anaesthesist 51:787–799
Kreimeier U, Lackner CK, Prückner S, Ruppert M, Peter K (2003) Neue Strategien in der Volumenersatztherapie beim Polytrauma. Notfall Rettungsmed 6:77–88
Krismer AC, Wenzel V, Lindner KH et al. (2004) Influence of positive end-expiratory pressure ventilation on survival during severe hemorrhagic shock. Ann Emerg Med (accepted for publication pending revision)
Krismer AC, Wenzel V, Lindner KH et al. (2004) Influence of negative pressure ventilation on hemodynamic variables and survival during severe hemorrhagic shock. (Accepted for publication pending revision)
Kurz A, Sessler DI, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334:1209–1215
Kwan I, Bunn F, Roberts I (2003) Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev CD002245
Landry DW, Oliver JA (1992) The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dogs. J Clin Invest 89:2071–2074
Leonov Y, Safar P, Sterz F, Stezoski SW (2002) Extending the golden hour of hemorrhagic shock tolerance with oxygen plus hypothermia in awake rats. An exploratory study. Resuscitation 52:193–202
Lurie K (2002) Mechanical devices for cardiopulmonary resuscitation: an update. Emerg Med Clin North Am 20:771–784
Lurie KG, Zielinski T, Voelckel W, McKnite S, Plaisance P (2002) Augmentation of ventricular preload during treatment of cardiovascular collapse and cardiac arrest. Crit Care Med 30:S162–165
Lurie KG, Barnes TA, Zielinski TM, McKnite SH (2003) Evaluation of a prototypic inspiratory impedance threshold valve designed to enhance the efficiency of cardiopulmonary resuscitation. Respir Care 48:52–57
Lurie KG, Zielinski TM, McKnite SH et al. (2004) Treatment of hypotension in pigs with an inspiratory impedance threshold device: a feasibility study. Crit Care Med 32:1555–1562
Lynn M, Jerokhimov I, Jewelewicz D et al. (2002) Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study. J Trauma 52:703–707
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U (2002) Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 28 [Suppl 2]:S241–247
MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M (2003) Early coagulopathy predicts mortality in trauma. J Trauma 55:39–44
Majde JA (2003) Animal models for hemorrhage and resuscitation research. J Trauma 54:S100–105
Mapstone J, Roberts I, Evans P (2003) Fluid resuscitation strategies: a systematic review of animal trials. J Trauma 55:571–589
Mardel SN, Saunders FM, Allen H et al. (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80:204–207
Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431–438; discussion 438–439
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E (2002) Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 49:S15–20
Mauritz W, Schimetta W, Oberreither S, Polz W (2002) Are hypertonic hyperoncotic solutions safe for prehospital small-volume resuscitation? Results of a prospective observational study. Eur J Emerg Med 9:315–319
Migita R, Gonzales A, Gonzales ML, Vandegriff KD, Winslow RM (1997) Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 82:1995–2002
Mizushima Y, Wang P, Cioffi WG, Bland KI, Chaudry IH (2000) Restoration of body temperature to normothermia during resuscitation following trauma-hemorrhage improves the depressed cardiovascular and hepatocellular functions. Arch Surg 135:175–181
Mizushima Y, Wang P, Cioffi WG, Bland KI, Chaudry IH (2000) Should normothermia be restored and maintained during resuscitation after trauma and hemorrhage? J Trauma 48:58–65
Morales D, Madigan J, Cullinane S et al. (1999) Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100:226–229
Morgan BC, Martin WE, Hornbein TF, Crawford EW, Guntheroth WG (1966) Hemodynamic effects of intermittent positive pressure respiration. Anesthesiology 27:584–590
Negovsky VA (1988) Postresuscitation disease. Crit Care Med 16:942–946
Nolan J (2001) Fluid resuscitation for the trauma patient. Resuscitation 48:57–69
Norio H, Takasu A, Kawakami M, Saitoh D, Sakamoto T, Okada Y (2002) Rapid body cooling by cold fluid infusion prolongs survival time during uncontrolled hemorrhagic shock in pigs. J Trauma 52:1056–1061
Pepe PE, Raedler C, Lurie KG, Wigginton JG (2003) Emergency ventilatory management in hemorrhagic states: elemental or detrimental? J Trauma 54:1048–1055
Pieber D, Horina G, Sandner-Kiesling A, Pieber TR, Heinemann A (1999) Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats. Cardiovasc Res 44:166–175
Prueckner S, Safar P, Kentner R, Stezoski J, Tisherman SA (2001) Mild hypothermia increases survival from severe pressure-controlled hemorrhagic shock in rats. J Trauma 50:253–262
Przybelski RJ, Daily EK, Micheels J et al. (1999) A safety assessment of diaspirin cross-linked hemoglobin (DCLHb) in the treatment of hemorrhagic, hypovolemic shock. Prehospital Disaster Med 14:251–264
Raedler C, Voelckel WG, Wenzel V et al. (2004) Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg 98:1759–1766
Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E (2001) Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet 357:385–387
Rosemurgy A, Norris P, Olson S, Hurst J, Albrink M (1993) Prehospital traumatic cardiac arrest: the cost of futility. J Trauma 35:468–473
Safar P, Tisherman S (2003) Trauma resuscitation: what have we learned in the past 50 years? Curr Opin Anaesth 16:133–138
Salzman AL, Vromen A, Denenberg A, Szabo C (1997) K(ATP)-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol 272:H688–694
Samniah N, Voelckel WG, Zielinski TM, McKnite S, Patterson R, Benditt DG, Lurie KG (2003) Feasibility and effects of transcutaneous phrenic nerve stimulation combined with an inspiratory impedance threshold in a pig model of hemorrhagic shock. Crit Care Med 31:1197–1202
Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316:961–964
Schultz SC, Hamilton IN Jr, Malcolm DS (1993) Use of base deficit to compare resuscitation with lactated Ringer’s solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 35:619–625
Sharma AC, Singh G, Gulati A (1995) Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 269:H1379–1388
Shoemaker WC, Peitzman AB, Bellamy R et al. (1996) Resuscitation from severe hemorrhage. Crit Care Med 24:S12–23
Siegel JH, Fabian M, Smith JA, Costantino D (1997) Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 42:199–212
Sigurdsson G, Yannopoulos D, McKnite SH, Lurie KG (2003) Cardiorespiratory interactions and blood flow generation during cardiac arrest and other states of low blood flow. Curr Opin Crit Care 9:183–188
Silbergleit R, Satz W, Lee DC, McNamara RM (1998) Hypothermia from realistic fluid resuscitation in a model of hemorrhagic shock. Ann Emerg Med 31:339–343
Simma B, Burger R, Falk M, Sacher P, Fanconi S (1998) A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer’s solution versus hypertonic saline. Crit Care Med 26:1265–1270
Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G Jr (1999) Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282:1857–1864
Sloan EP, Koenigsberg M, Brunett PH, Bynoe RP, Morris JA, Tinkoff G, Dalsey WC, Ochsner MG (2002) Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock. J Trauma 52:887–895
Spahn DR (2002) Artificial oxygen carriers: status 2002. Vox Sang 83 [Suppl 1]:281–285
Spence RK, McCoy S, Costabile J et al. (1990) Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients. Crit Care Med 18:1227–1230
Stadlbauer KH, Wagner-Berger HG, Raedler C et al. (2003) Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 98:699–704
Stern SA, Dronen SC, McGoron AJ et al. (1995) Effect of supplemental perfluorocarbon administration on hypotensive resuscitation of severe uncontrolled hemorrhage. Am J Emerg Med 13:269–275
Stockinger ZT, McSwain NE Jr (2004) Additional evidence in support of withholding or terminating cardiopulmonary resuscitation for trauma patients in the field. J Am Coll Surg 198:227–231
Suzuki A, Iwamoto T, Sato S (2002) Effects of inspiratory oxygen concentration and ventilation method on a model of hemorrhagic shock in rats. Exp Anim 51:477–483
Szabo C, Salzman AL (1996) Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock 5:391–394
Tisherman SA (2004) Suspended animation for resuscitation from exsanguinating hemorrhage. Crit Care Med 32:S46–50
Traverso L, Moore C, Tillman F (1984) A clinically applicable exsanguination shock model in swine. Circ Shock 12:1–7
Trupka A, Waydhas C, Nast-Kolb D, Schweiberer L (1994) Early intubation in severely injured patients. Eur J Emerg Med 1:1–8
Ubl J, Murer H, Kolb HA (1988) Hypotonic shock evokes opening of Ca2+-activated K channels in opossum kidney cells. Pflugers Arch 412:551–553
Voelckel WG, Wenzel V (2003) Managing hemorrhagic shock: fluids on the way out—Drugs on the way in? Crit Care Med 31:2552–2553
Voelckel WG, Lurie KG, Lindner KH, Zielinski T, McKnite S, Krismer AC, Wenzel V (2000) Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth Analg 91:627–634
Voelckel WG, Raedler C, Wenzel V et al. (2003) Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med 31:1160–1165
Wade CE, Grady JJ, Kramer GC, Younes RN, Gehlsen K, Holcroft JW (1997) Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma 42:S61–65
Webb W, Wax S (1979) Post-traumatic respiratory distress syndrome. Compr Ther 5:19–23
Winslow RM, Gonzales A, Gonzales ML, Magde M, McCarthy M, Rohlfs RJ, Vandegriff KD (1998) Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 85:993–1003
Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E (1993) Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med 21:218–223
Wright FL, Hua HT, Velmahos G, Thoman D, Demitriades D, Rhee PM (2004) Intracorporeal use of the hemostatic agent QuickClot in a coagulopathic patient with combined thoracoabdominal penetrating trauma. J Trauma 56:205–208
Yaffe L, Abbott D, Schulte B (2004) Smart aortic arch catheter: moving suspended animation from the laboratory to the field. Crit Care Med 32:S51–55
Zenati MS, Billiar TR, Townsend RN, Peitzman AB, Harbrecht BG (2002) A brief episode of hypotension increases mortality in critically ill trauma patients. J Trauma 53:232–236; discussion 236–237
Zhao K, Liu J, Jin C (2000) The role of membrane potential and calcium kinetic changes in the pathogenesis of vascular hyporeactivity during severe shock. Chin Med J (Engl) 113:59–64
Zhao KS, Huang X, Liu J et al. (2002) New approach to treatment of shock—Restitution of vasoreactivity. Shock 18:189–192
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Voelckel, W.G., von Goedecke, A., Fries, D. et al. Die Behandlung des hämorrhagischen Schocks. Anaesthesist 53, 1151–1167 (2004). https://doi.org/10.1007/s00101-004-0771-4
Issue Date:
DOI: https://doi.org/10.1007/s00101-004-0771-4
Schlüsselwörter
- Hämorrhagischer Schock
- Hypovolämie
- „Inspiratory threshold valve“
- Künstliche Sauerstoffträger
- Suspended animation
- Arginine-Vasopressin